SEC Form 4 · accession 0001225208-17-017239
COLGATE PALMOLIVE CO · CL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Victoria L Dolan
Officer — Chief Transformation Officer
Period of report
Nov 8, 2017
Accepted (ET)
Nov 13, 2017 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000021665
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 8, 2017 | M | 20,000 | $52.27 | A | 60,528 | D | |
| Common StockF3 | Nov 8, 2017 | S | 20,000 | $72.9119 | D | 40,528 | D | |
| Common Stock | Nov 9, 2017 | M | 10,000 | $52.27 | A | 50,528 | D | |
| Common StockF4 | Nov 9, 2017 | S | 10,000 | $73.0747 | D | 40,528 | D | |
| Common Stock | holding | — | — | — | 4,863 | I | By Issuer's 401(k) Plan Trustee |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $52.27 | Nov 8, 2017 | M | 20,000 | D | — | Sep 13, 2018 | Common Stock | 20,000 | 19,000 | D |
| Stock Option (Right to Buy)F5 | $52.27 | Nov 9, 2017 | M | 10,000 | D | — | Sep 13, 2018 | Common Stock | 10,000 | 9,000 | D |
Explanation of responses
- F1Exercise of stock options awarded under the issuer's employee stock option plan.
- F2Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding.
- F3Weighted average price, as these shares were sold in multiple transactions at prices ranging from $72.71 to $73.0003, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4Weighted average price, as these shares were sold in multiple transactions at prices ranging from $73.00 to $73.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2012 grant date.